Navigation Links
DSM and Opthea Sign Agreement to Manufacture Opthea's Lead Product for Eye Disease
Date:10/29/2013

rmation can be found at www.dsmbiologics.com and www.dsm.com.

Forward-looking statements
This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

For more information:Guy Tiene

Megan BaldwinDirector, Marketing and Communications

Chief Executive OfficerDSM Pharmaceutical Products

Opthea Pty. Ltd. tel +1 973 257 8tel +61 (3) 9826 0399 email guy.tiene@dsm.comemail megan.baldwin@opthea.comLidija Damjanovic

Opthea Media Enquiries – InternationalGlobal Marketing Manager

Lauren GlaserDSM Biologics

The Trout Group LLCtel: +61 466 099 329

tel +1 215 740 8468Email lidija.damjanovic@dsm.com  


'/>"/>
SOURCE DSM Pharmaceutical Products
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Misonix Announces New Distribution Agreement For Panama
3. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
4. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
5. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
6. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
7. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
8. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
9. MDHI in Agreement with Debt Holders - Portion of Convertible Debt and Additional 14M Warrants Cancelled -- Total of 101M Warrants Cancelled this Year
10. Novation Inks Supplier Contract Category Agreement for Masimo SET® pulse oximetry and rainbow® SET Pulse CO-Oximetry™
11. Wintherix and Epitherix reaches an agreement with Pfizer and The Pfizer Incubator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 20, 2015 ... addition of the "Global Post-traumatic Stress Disorder Therapeutics ... The global PTSD therapeutics market to grow at a ... This report covers the present scenario and the growth ... period 2015-2019. To calculate the market size, the report ...
(Date:7/28/2015)... July 28, 2015 According to a ... Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, ... - Forecast to 2020", published by MarketsandMarkets, the European Injectable ... 2020 from $114.7 Billion in 2015, growing at a CAGR ... 230 market data T ables ...
(Date:7/27/2015)... SEATTLE , July 28, 2015 CTI ... it plans to report its second quarter 2015 financial ... of the U.S. financial markets. Following the announcement, members ... call to discuss the results and provide a general ... Access to the event can be obtained as follows: ...
Breaking Medicine Technology:Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019 - Growing Number of Accidents and Violence Worldwide Drives the Market 2European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 2European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 3European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 4CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2
... Model of Diabetes with Haptoglobin 2-2 Genotype Show, ... Transport, MONTVALE, N.J., March 31 Synvista,Therapeutics, ... a study of diabetic mice,with the Haptoglobin 2-2 ... Haptoglobin (Hp)-Hemoglobin (Hb) complex may result in a ...
... is now enrolling ... patients, ... announced today the start of a Phase III clinical trial,studying LY450139, an ... LY450139 is being tested,to see if it can slow the progression associated ...
Cached Medicine Technology:Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions 2Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions 3Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions 4Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 2Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 3Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 4Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 5Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 6
(Date:7/28/2015)... ... July 28, 2015 , ... ADLINK Technology, a ... edge devices that enable the Internet of Things (IoT), announced its new medical ... to provide exceptional computing power and multitasking capabilities. The MLC 4-21 is completely ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... much-anticipated U.S. commercial launch of its ORTHALIGN PLUS® system, a palm-sized, single-use navigation ... , “OrthAlign successfully combined precision with practicality in a revolutionary way for ...
(Date:7/28/2015)... ... July 28, 2015 , ... On July 16th NPR ... schedule the hearing of proposed bills and laws revolving the implementation of a small ... date. Some vigilante ministers are continuing to hand out clean needles to drug users ...
(Date:7/28/2015)... ... 2015 , ... BiologicsMD, Inc. , a privately held ... of bone disorders and conditions of hair loss, announced that the U.S. Patent ... Binding-Domain and Parathyroid Hormone". The issued patent claims methods of use for promoting ...
(Date:7/28/2015)... ... July 28, 2015 , ... Fertility specialist Dr. Lisa Hasty ... 2015” by Atlanta Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has ... colleagues and peers in the metro area as one of the most respected doctors ...
Breaking Medicine News(10 mins):Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3
... has revealed how change in body temperature impacts the ... Conti of the Scripps Research Institute in La Jolla, ... to prolong life and found that the lifespan of ... core body temperature, reported the health portal News Medical., ...
... meeting on breathing disorders in Paris discussed the ongoing research ... need to revamp the more than a century old test ... which the strains of TB have become resistant. ... the 37th world congress of the Union for breathing health ...
... restaurants to list the calories of all items offered in ... already offered the information regarding calories of various items offered by ... the back of tray liners and in restaurant brochures. ... are resisting the idea. It is a change to be welcomed ...
... Yoga is a path to optimal health by achieving a healthy ... undertaken by many for over 5,000 years//. ,The November ... and its health benefits. ,Yoga has its roots in ... of relaxation, postures and breathing. Several forms of yoga have evolved ...
... 100 health professionals put their heads together to thrash ... is weakening the healthcare system in Queensland. The// representatives ... nuclear medicine technologists in state-run hospitals has warned that ... staff, in the absence of any action. ...
... primary health care for patients that was released by ... developed// countries, except the U.S. ,In the ... it was found that Canada lagged in several aspects ... records, doctors availability after hours, multi-discipline teams for treatment ...
Cached Medicine News:
... assays are designed for ... 2000, a high-throughput, continuous ... IMMULITE 2000 offers testing ... a rapidly expanding menu ...
... from KUBTEC is a dual capability system with ... representation of the specimen under test. While the ... images, the micro focus source also allows the ... standard 2D images. The 100 mm x 100 ...
... specimen radiography. The XPERT represents a research tool ... gray in every digital x-ray image, thus being ... that heretofore were lost to the human eye. ... 2 to 8 x 8 in size, multi-color ...
The Triage Profiler Shortness of Breath Panel provides rapid risk assessment and differential diagnosis of patients presenting to the emergency department with shortness of breath and risk assessment...
Medicine Products: